Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Other Accumulated Expenses (2018 - 2025)

TELA Bio (TELA) has 8 years of Other Accumulated Expenses data on record, last reported at $1.2 million in Q3 2025.

  • For Q3 2025, Other Accumulated Expenses rose 42.33% year-over-year to $1.2 million; the TTM value through Sep 2025 reached $1.2 million, up 42.33%, while the annual FY2024 figure was $955000.0, 81.21% up from the prior year.
  • Other Accumulated Expenses reached $1.2 million in Q3 2025 per TELA's latest filing, down from $1.2 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $1.2 million in Q2 2025 and bottomed at $51000.0 in Q1 2022.
  • Average Other Accumulated Expenses over 5 years is $488210.5, with a median of $278000.0 recorded in 2023.
  • Peak YoY movement for Other Accumulated Expenses: surged 6744.44% in 2021, then plummeted 91.72% in 2022.
  • A 5-year view of Other Accumulated Expenses shows it stood at $79000.0 in 2021, then surged by 84.81% to $146000.0 in 2022, then surged by 260.96% to $527000.0 in 2023, then soared by 81.21% to $955000.0 in 2024, then grew by 20.42% to $1.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $1.2 million in Q3 2025, $1.2 million in Q2 2025, and $1.1 million in Q1 2025.